Literature DB >> 27925146

Assessment of Diagnostics Tools for Sarcopenia Severity Using the Item Response Theory (IRT).

M Steffl1, M Musalek, V Kramperova, M Petr, E Kohlikova, I Holmerova, L Volicer.   

Abstract

OBJECTIVE: To use the item response theory (IRT) methods to examine the degree to which the four selected tools reflect sarcopenia and to arrange them according to their ability to estimate sarcopenia severity.
DESIGN: A cross-sectional study aimed at verifying the possibilities of using diagnostic tools for sarcopenia. SETTING AND PARTICIPANTS: The study included residents living in an assisted living unit at the Senior Centre in Blansko (South Moravia, Czech Republic) (n=77). Sarcopenia was estimated according to the proposals of the European Working Group on Sarcopenia in Older People (EWGSOP) using calf circumference, the EWGSOP algorithm, hand grip strength, and the Short Physical Performance Battery (SPPB).
RESULTS: The results from the IRT model showed that these four methods indicate strong unidimensionality so that they measure the same latent variable. The methods ranked according to the discrimination level ranging from high to low discrimination where the calf circumference was the most discriminatory (Hi = 0.86) and the SPPB together with hand grip strength were the least discriminatory (both Hi = 0.44).
CONCLUSION: We are recommending to identify mild sarcopenia by SPPB or hand grip strength, moderate sarcopenia by the EWGSOP algorithm and severe sarcopenia by the calf circumference.

Entities:  

Mesh:

Year:  2016        PMID: 27925146     DOI: 10.1007/s12603-016-0713-2

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  21 in total

1.  Item response theory and the measurement of clinical change.

Authors:  Steven P Reise; Mark G Haviland
Journal:  J Pers Assess       Date:  2005-06

2.  A survey of theory and methods of invariant item ordering.

Authors:  K Sijtsma; B W Junker
Journal:  Br J Math Stat Psychol       Date:  1996-05       Impact factor: 3.380

3.  Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults.

Authors:  X Wen; P An; W C Chen; Y Lv; Q Fu
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

4.  Comprehensive nutritional status in sarco-osteoporotic older fallers.

Authors:  Y R Huo; P Suriyaarachchi; F Gomez; C L Curcio; D Boersma; P Gunawardene; O Demontiero; G Duque
Journal:  J Nutr Health Aging       Date:  2015-04       Impact factor: 4.075

5.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

6.  Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study.

Authors:  Yves Rolland; Valérie Lauwers-Cances; Maxime Cournot; Fati Nourhashémi; William Reynish; Daniel Rivière; Bruno Vellas; Hélène Grandjean
Journal:  J Am Geriatr Soc       Date:  2003-08       Impact factor: 5.562

7.  Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women.

Authors:  Ian Janssen; Richard N Baumgartner; Robert Ross; Irwin H Rosenberg; Ronenn Roubenoff
Journal:  Am J Epidemiol       Date:  2004-02-15       Impact factor: 4.897

8.  PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.

Authors:  M Cesari; R Fielding; O Bénichou; R Bernabei; S Bhasin; J M Guralnik; A Jette; F Landi; M Pahor; L Rodriguez-Manas; Y Rolland; R Roubenoff; A J Sinclair; S Studenski; T Travison; B Vellas
Journal:  J Frailty Aging       Date:  2015

9.  Lawton IADL scale in dementia: can item response theory make it more informative?

Authors:  Sarah McGrory; Susan D Shenkin; Elizabeth J Austin; John M Starr
Journal:  Age Ageing       Date:  2013-11-07       Impact factor: 10.668

10.  Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.

Authors:  Robert R McLean; Michelle D Shardell; Dawn E Alley; Peggy M Cawthon; Maren S Fragala; Tamara B Harris; Anne M Kenny; Katherine W Peters; Luigi Ferrucci; Jack M Guralnik; Stephen B Kritchevsky; Douglas P Kiel; Maria T Vassileva; Qian-Li Xue; Subashan Perera; Stephanie A Studenski; Thuy-Tien L Dam
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more
  5 in total

1.  Prevalence and Diagnosis of Sarcopenia in Residential Facilities: A Systematic Review.

Authors:  Ana Isabel Rodríguez-Rejón; María Dolores Ruiz-López; Carmina Wanden-Berghe; Reyes Artacho
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

2.  Editorial: Defining Undernutrition (Malnutrition) in Older Persons.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  Diagnosis of Sarcopenia in Long-Term Care Homes for the Elderly: the Sensitivity and Specificity of Two Simplified Algorithms with Respect to the EWGSOP Consensus.

Authors:  A I Rodriguez-Rejon; R Artacho; A Puerta; A Zuñiga; M D Ruiz-Lopez
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Use of item response theory to develop a shortened version of the EORTC QLQ-BR23 scales.

Authors:  Juan Xia; Zheng Tang; Peng Wu; Jiwei Wang; Jinming Yu
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

5.  Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients.

Authors:  Damien Botsen; Marie-Amélie Ordan; Coralie Barbe; Camille Mazza; Marine Perrier; Johanna Moreau; Mathilde Brasseur; Yohann Renard; Barbara Taillière; Florian Slimano; Eric Bertin; Olivier Bouché
Journal:  BMC Cancer       Date:  2018-10-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.